![Edwin Rock](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edwin Rock
Directeur Technique/Scientifique/R&D chez GLYCOMIMETICS, INC.
Fortune : 184 389 $ au 31/05/2024
Profil
Edwin P.
Rock is currently the Chief Medical Officer & Senior Vice President at GlycoMimetics, Inc. Prior to his current position, he served as the Chief Medical Officer at Partner Therapeutics, Inc. Dr. Rock completed his undergraduate degree at Swarthmore College and obtained his doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
GLYCOMIMETICS, INC.
1,06% | 21/06/2024 | 680 403 ( 1,06% ) | 184 389 $ | 31/05/2024 |
Postes actifs de Edwin Rock
Sociétés | Poste | Début |
---|---|---|
GLYCOMIMETICS, INC. | Directeur Technique/Scientifique/R&D | 06/09/2022 |
Anciens postes connus de Edwin Rock
Sociétés | Poste | Fin |
---|---|---|
Partner Therapeutics, Inc.
![]() Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Edwin Rock
Swarthmore College | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GLYCOMIMETICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Partner Therapeutics, Inc.
![]() Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |